Intensivmedizinische Aspekte bei hämatologischen und onkologischen Erkrankungen

• Literatur

• 1 Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007; 25: 3274-3280
• 2 Mariotto AB, Yabroff KR, Shao Y et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103: 117-128
• 3 Taccone FS, Artigas AA, Sprung CL et al. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009; 13: R15
• 4 Azoulay E, Soares M, Darmon M et al. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 2011; 1: 5
• 5 Puxty K, McLoone P, Quasim T et al. Survival in solid cancer patients following intensive care unit admission. Intensive Care Med 2014; 40: 1409-1428
• 6 Azoulay E, Mokart D, Pene F et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium – a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 2013; 31: 2810-2818
• 7 Zuber B, Tran TC, Aegerter P et al. Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 2012; 40: 55-62
• 8 Lecuyer L, Chevret S, Guidet B et al. Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 2008; 32: 748-754
• 9 Pene F, Percheron S, Lemiale V et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008; 36: 690-696
• 10 Vandijck DM, Benoit DD, Depuydt PO et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008; 34: 847-855
• 11 Gruson D, Vargas F, Hilbert G et al. Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia. Intensive Care Med 2004; 30: 965-971
• 12 Azoulay E, Lemiale V, Mokart D et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 2014; 40: 1106-1114
• 13 Chaoui D, Legrand O, Roche N et al. Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 2004; 18: 670-675
• 14 Legrand M, Max A, Peigne V et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43-49
• 15 Ferrer R, Artigas A, Levy MM et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299: 2294-2303
• 16 Staudinger T, Stoiser B, Mullner M et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322-1328
• 17 Oeyen SG, Benoit DD, Annemans L et al. Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Med 2013; 39: 889-898
• 18 Massion PB, Dive AM, Doyen C et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002; 30: 2260-2270
• 19 Schellongowski P, Staudinger T, Kundi M et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 2011; 96: 231-237
• 20 Schellongowski P, Wohlfahrth P, Michael K et al. Incidence of Intensive Care Unit Admission, Outcome, and Post Intensive Care Survival in Patients with Acute Lymphocytic Leukemia or Burkitt Lymphoma (ASH Congress Abstract). Blood 2014; 124: 2633
• 21 Wohlfarth P, Carlström A, Staudinger T et al. Incidence of Intensive Care Unit Admission, Outcome, and Post Intensive Care Survival in Patients with Diffuse Large B-Cell Lymphoma. Leuk Lymphoma 2015; DOI
• 22 Azoulay E, Recher C, Alberti C et al. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999; 25: 1395-1401
• 23 Wohlfarth P, Ullrich R, Staudinger T et al. Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care 2014; 18: R20
• 24 Rabbat A, Chaoui D, Montani D et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol 2005; 129: 350-357
• 25 Roze des Ordons AL, Chan K, Mirza I et al. Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study. BMC Cancer 2010; 10: 516
• 26 Azoulay E, Kouatchet A, Jaber S et al. Noninvasive mechanical ventilation in patients having declined tracheal intubation. Intensive Care Med 2013; 39: 292-301
• 27 van Vliet M, van den Boogaard M, Donnelly JP et al. Long-Term Health Related Quality of Life following Intensive Care during Treatment for Haematological Malignancies. PLoS One 2014; 9: e87779
• 28 Darmon M, Azoulay E, Alberti C et al. Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 2002; 28: 1775-1780
• 29 Kress JP, Christenson J, Pohlman AS et al. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160: 1957-1961
• 30 Lecuyer L, Chevret S, Thiery G et al. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-814
• 31 Zapol WM, Snider MT, Hill JD et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242: 2193-2196
• 32 Kompanje EJ, Piers RD, Benoit DD. Causes and consequences of disproportionate care in intensive Care Med. Curr Opin Crit Care 2013; 19: 630-635
• 33 Thiery G, Azoulay E, Darmon M et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406-4413
• 34 Hanzelka KM, Yeung SC, Chisholm G et al. Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center. Support Care Cancer 2013; 21: 727-734
• 35 Mokart D, Lambert J, Schnell D et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 2013; 54: 1724-1729
• 36 Mokart D, Saillard C, Sannini A et al. Neutropenic cancer patients with severe sepsis: need for antibiotics in the first hour. Intensive Care Med 2014; 40: 1173-1174
• 37 Squadrone V, Massaia M, Bruno B et al. Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med 2010; 36: 1666-1674
• 38 Lengline E, Raffoux E, Lemiale V et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 2012; 53: 1352-1359
• 39 Schellongowski P. Cancer patients in the intensive care unit. Goals of therapy, ethics, and palliation. Med Klin Intensivmed Notfmed 2013; 108: 203-208
• 40 accessed at https://www.capc.org/ipal/ipal-icu/
• 41 Hilbert G, Gruson D, Vargas F et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481-487
• 42 Azoulay E, Alberti C, Bornstain C et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-525
• 43 Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 2006; 32: 808-822
• 44 Azoulay E, Mokart D, Lambert J et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 1038-1046
• 45 Antonelli M, Conti G, Bufi M et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA 2000; 283: 235-241
• 46 Lemiale V, Resche-Rigon M, Mokart D et al. Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en reanimation onco-hematologique (Grrr-OH) study. Ann Intensive Care 2015; 5: 28
• 47 Lemiale V, Mokart D, Resche-Rigon M et al. Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial. JAMA 2015; 314: 1711-1719
• 48 Frat JP, Thille AW, Mercat A et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372: 2185-2196
• 49 Adda M, Coquet I, Darmon M et al. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 2008; 36: 2766-2772
• 50 Amado-Rodríguez L, Bernal T, López-Alonso I et al. Impact of Initial Ventilatory Strategy in Hematological Patients with Acute Respiratory Failure: a Systematic Review and Meta-Analysis. Crit Care Med 2016; 44: 1406-1413
• 51 Soares M, Salluh JI, Azoulay E. Noninvasive ventilation in patients with malignancies and hypoxemic acute respiratory failure: a still pending question. J Crit Care 2010; 25: 37-38
• 52 Thirumala R, Ramaswamy M, Chawla S. Diagnosis and management of infectious complications in critically ill patients with cancer. Crit Care Clin 2010; 26: 59-91
• 53 Azoulay E, Darmon E. Acute respiratory distress syndrome during neutropenia recovery. Crit Care 2010; 14: 114
• 54 Balsat M, Xhaard A, Lengline E et al. Worsening of Respiratory Status during Neutropenia Recovery in Noncritically Ill Hematological Patients: Results of a Prospective Multicenter Study. Respiration 2015; 90: 229-234
• 55 Penack O, Becker C, Buchheidt D et al. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol 2014; 93: 1083-1095
• 56 Maschmeyer G, Carratala J, Buchheidt D et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 2015; 26: 21-33
• 57 Wohlfarth P, Staudinger T, Sperr WR et al. Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol 2014; 93: 1629-1636
• 58 Benoit DD, Depuydt PO, Vandewoude KH et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 2006; 32: 93-99
• 59 Song JU, Suh GY, Chung MP et al. Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer 2011; 19: 491-495
• 60 Cairo MS, Coiffier B, Reiter A et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010; 149: 578-586
• 61 Schellongowski P, Staudinger T. Leukostasis and tumor lysis: important complications of hyperleukocytosis. Internist (Berl) 2013; 54: 1051-1060
• 62 Coiffier B, Altman A, Pui CH et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008; 26: 2767-2778
• 63 Azoulay E, Canet E, Raffoux E et al. Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur Respir J 2012; 39: 648-653
• 64 Sanz MA, Grimwade D, Tallman MS et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009; 113: 1875-1891
• 65 Szczepiorkowski ZM, Winters JL, Bandarenko N et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177
• 66 Lengline E, Chevret S, Moreau AS et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015; 50: 840-845
• 67 Afessa B, Azoulay E. Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin 2010; 26: 133-150
• 68 von Bergwelt-Baildon M, Holtick U, Hallek MJ et al. Hematopoietic stem cell transplantation: bone marrow and blood stem cells. Internist (Berl) 2014; 55: 1306-1312